missing translation for 'onlineSavingsMsg'
Learn More

SCN9A/Nav1.7 Rabbit anti-Human, Polyclonal, Proteintech

Rabbit Polyclonal Antibody

133.80 CHF - 381.34 CHF

Spezifikation

Antigen SCN9A/Nav1.7
Konzentration 0.28 mg/mL
Anwendungen Immunofluorescence, Immunocytochemistry, Immunohistochemistry (Paraffin)
Klassifikation Polyclonal
Konjugat Unconjugated
Mehr Spezifikationen ansehen

Produkte 2
Produktcode Marke Menge Preis Menge & Verfügbarkeit  
Produktcode Marke Menge Preis Menge & Verfügbarkeit  
16839784
Unterlagen ansehen Aktionsdetails
Proteintech
20257-1-AP-20UL
20 μL
133.80 CHF
20 Mikroliter
Alternative Produkte anzeigen
Sparen Sie bis zu 
»
Verfügbar ab: 14-05-2024
Sie sich ein, um den Lagerbestand zu sehen
Zum Warenkorb hinzufügen
 
16829784
Unterlagen ansehen Aktionsdetails
Proteintech
20257-1-AP-150UL
150 μL
381.34 CHF
150 Mikroliter
Alternative Produkte anzeigen
Sparen Sie bis zu 
»
Verfügbar ab: 14-05-2024
Sie sich ein, um den Lagerbestand zu sehen
Zum Warenkorb hinzufügen
 
Beschreibung

Beschreibung

The antibody is specific to SCN9A.

Epithelial sodium channels are amiloride-sensitive members of the Degenerin/epithelial sodium channel (Deg/ENaC) superfamily of ion channels. Members of this superfamily of ion channels share organizational similarity in that they all possess two short intracellular amino and carboxyl termini, two short membrane spanning segments, and a large extracellular loop with a conserved cysteine-rich region. There are three homologous isoforms of the ENaC (alpha, beta, and gamma) protein. ENaC in the kidney, lung, and colon plays an essential role in trans-epithelial sodium and fluid balance. ENaC also mediates aldosterone-dependent sodium reabsorption in the distal nephron of the kidney, thus regulating blood pressure. ENaC is thought to be regulated, in part, through association with the cystic fibrosis transmembrane conductance regulator (CFTR) chloride ion channel. Gain-of-function mutations in beta- or gamma-ENaC can cause severe arterial hypertension (Liddels syndrome) and loss-of-function mutations in alpha- or beta-ENaC causes pseudohypoaldosteronism (PHA-1).
Spezifikation

Spezifikation

SCN9A/Nav1.7
Immunofluorescence, Immunocytochemistry, Immunohistochemistry (Paraffin)
Unconjugated
Rabbit
Human
Q15858
6335
Peptide
Primary
-20°C
SCN9A
0.28 mg/mL
Polyclonal
Liquid
RUO
PBS with 50% glycerol and 0.02% sodium azide; pH 7.3
ETHA, hNE Na, Nav1.7, NE NA, NENA, Neuroendocrine sodium channel, Peripheral sodium channel 1, PN1, SCN9A
SCN9A
IgG
Antigen Affinity Chromatography
Antibody
Videos
Sicherheitsdatenblatt (SDS)
Dokumentation

Dokumentation

Product Certifications